06.04.2020 • NewsDede WillamsNouryonSasol

Nouryon to Take Sasol’s TEAL Business

Nouryon to Take Sasol’s TEAL Business (c) Nouryon
Nouryon to Take Sasol’s TEAL Business (c) Nouryon

Nouryon said it plans to acquire the merchant triethyl aluminum (TEAL) business of South African petchems giant Sasol. Terms were not disclosed.

The deal is expected to be finalized during the second quarter, and Nouryon said it plans to gradually incorporate Sasol’s production into its Rotterdam operation.

Metal alkyls are used in catalysts such as Ziegler-Natta, single-site and other specialized systems for production of high-volume plastics such as polypropylene and polyethylene includes a specialty fleet of returnable cylinders.

For the former Akzo Nobel specialty chemicals arm, the acquisition is the latest in a series of moves aimed at significantly increasing its footprint in the metal alkyls market. It follows the expansion of capacity at Rotterdam and the acquisition of Zhejiang Friend Chemical, China’s largest producer of TEAL.

“Our ambition is to strengthen our leadership position in catalysts to the global polymer industry and this acquisition allows us to take the next step in that journey,” said Johan Landfors, president of Technology Solutions at Nouryon.

Landfors added that the company will continue to focus on building this part of its business and expects to make more bolt-on additions to it in the future.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.